The phosphor screen scanner market consists of medical imaging devices that digitize phosphor screen plates used in radiology and dental applications. Phosphor screens are used in X-ray imaging and store X-ray data as a latent image. Phosphor screen scanners scan these plates and convert the stored X-ray information into a digital format such as DICOM that can be viewed and processed on computers. The devices find widespread application in general radiography, mammography, orthopedic imaging, and dental applications. The global phosphor screen scanner market is estimated to be valued at US$ 288 Bn in 2023 and is expected to exhibit a CAGR of 10.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
One of the major drivers for the growth of the phosphor screen scanner market is the increasing adoption of digital radiology and molecular diagnostics. Digital radiography replaces conventional X-ray film with phosphor screen plates and scanners, offering advantages such as improved image quality, reduced X-ray dosage, and instant image availability. It is widely being adopted across hospitals and diagnostic centers. Furthermore, the rising incidence of chronic diseases such as cancer is leading to increasing diagnostic imaging procedures. This in turn is promoting the demand for phosphor screen scanners in conjunction with X-ray imaging equipment. In addition, technological advancements resulting in more sensitive phosphor screens and high-resolution scanners are further supporting the market growth over the forecast period.

SWOT Analysis
Strength: The phosphor screen scanner market size has strong growth potential owing to rising demand for digital radiography systems. Phosphor screen scanners offer high-resolution images and are less expensive than traditional systems. They are also portable and allow for quick scanning of images.

Weakness: Phosphor screen scanners have some limitations compared to newer digital options. They require specialized phosphor plates and chemicals for developing images. The plates also have a limited useful lifetime and need replacement. Phosphor screen scanners also cannot perform real-time imaging.

Opportunity: Growth opportunities exist in emerging markets as healthcare infrastructure improves. Asian countries are expected to see higher adoption rates for phosphor screen scanners. Enhanced models with better image quality and portability also provide room for innovation. Integrating artificial intelligence could help automate image analysis.

Threats: Stiff competition exists from newer digital radiography technologies like CR and DR systems. These offer advantages like real-time imaging, lower operating costs, and wider applications. Strict regulations around healthcare technologies also pose compliance challenges. Rising environmental concerns around disposal of phosphor plates act as a restraint.

Key Takeaways
The global phosphor screen scanner market is expected to witness high growth over the forecast period driven by widespread applications in hospitals, clinics and diagnostic centers.

Regional analysis: The Asia Pacific region holds the leading share of the global phosphor screen scanner market currently. China dominates the APAC market owing to its large population and healthcare sector expansion programs. India is another highly lucrative market and is expected to see a double digit CAGR through 2031. This can be attributed to growing government focus on universal healthcare and increasing investments in medical infrastructure development projects.

Key players: Key players operating in the phosphor screen scanner market are Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundation Medicine, Inc. These companies are focusing on product launches and partnerships to strengthen their positions.

Get more insights on this topic: https://www.newswirestats.com/phosphor-screen-scanner-market-size-and-outlook/